HealthTree

Your Feed

Filter by

See content from

Back to the latest

The Komet-001 Trial is Open to Patients with Relapsed or Refractory AML who have NPM1 Mutations

The Komet-001 Trial is Open to Patients with Relapsed or Refractory AML who have NPM1 Mutations image

Thumbnail for How is AML therapy changed based on fitness status?

Playlist: Geriatric Care and AML

How is AML therapy changed based on fitness status?

Video details & playlist

Smart Snacking- How to Choose a Satisfying Snack image

Smart Snacking- How to Choose a Satisfying Snack

01:00PM - 02:00PM EDT

Watch Recording

Avoiding Constipation During Myeloma Treatment (With Helpful Recipes)

Avoiding Constipation During Myeloma Treatment (With Helpful Recipes) image

Thumbnail for All About Thalomid (Thalidomide)

Playlist: Know Your Myeloma Therapy

All About Thalomid (Thalidomide)

Video details & playlist

Thumbnail for All About Ninlaro (Ixazomib)

Playlist: Know Your Myeloma Therapy

All About Ninlaro (Ixazomib)

Video details & playlist

Feeling Incurably Blessed: Ramae Hamrin's Myeloma Story

Feeling Incurably Blessed: Ramae Hamrin's Myeloma Story image

How Should Patients Interpret MRD Results?

How Should Patients Interpret MRD Results? image

Donor Age Proves to be an Important Factor for Half-Matched Allogeneic Bone Marrow Transplant Recipients

Donor Age Proves to be an Important Factor for Half-Matched Allogeneic Bone Marrow Transplant Recipients image

James Bond: Surviving Multiple Myeloma Since 1992

James Bond: Surviving Multiple Myeloma Since 1992 image

Increased Risk of Atrial Fibrillation for Multiple Myeloma Patients

Increased Risk of Atrial Fibrillation for Multiple Myeloma Patients image

ASCO 2021: MRD Negativity, Going with the Flow, NGS, Mass Spec, or PET

ASCO 2021: MRD Negativity, Going with the Flow, NGS, Mass Spec, or PET image

New CAR T Therapy Shows 100% Overall Response Rate in Relapsed and Refractory Multiple Myeloma

New CAR T Therapy Shows 100% Overall Response Rate in Relapsed and Refractory Multiple Myeloma image

Multiple Myeloma Cases Double Worldwide Since 1990

Multiple Myeloma Cases Double Worldwide Since 1990 image

Recent Drug Approvals for AML Part 2: IDH Inhibitors

Recent Drug Approvals for AML Part 2: IDH Inhibitors image

Thumbnail for All About Xpovio (Selinexor)

Playlist: Know Your Myeloma Therapy

All About Xpovio (Selinexor)

Video details & playlist

Thumbnail for All About Kyprolis (Carfilzomib)

Playlist: Archived Know Your Therapy Lessons

All About Kyprolis (Carfilzomib)

Video details & playlist

Thumbnail for All About Revlimid (Lenalidomide)

Playlist: Know Your Myeloma Therapy

All About Revlimid (Lenalidomide)

Video details & playlist

ASCO 2021: FDA grants Breakthrough Therapy Designation to Teclistamab, a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

ASCO 2021: FDA grants Breakthrough Therapy Designation to Teclistamab, a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma image

Utilizing Precision Diagnostics to Identify High Risk Myeloma at Diagnosis and Relapse image

Utilizing Precision Diagnostics to Identify High Risk Myeloma at Diagnosis and Relapse

01:00PM - 02:00PM EDT

Watch Recording

Salvage Therapy for Aggressive Types of Multiple Myeloma: Plasma Cell Leukemia and Extramedullary Myeloma

Salvage Therapy for Aggressive Types of Multiple Myeloma: Plasma Cell Leukemia and Extramedullary Myeloma image

ASCO 2021: Janssen Obtains FDA November 2021 Priority Review Date for Myeloma CAR T Cilta Cel Therapy

ASCO 2021: Janssen Obtains FDA November 2021 Priority Review Date for Myeloma CAR T Cilta Cel Therapy image

Finding Your Peace Through Qigong image

Finding Your Peace Through Qigong

07:00PM - 08:00PM EDT

Watch Recording

MC Community Event: Know Your Myeloma Therapy: BLENREP

MC Community Event: Know Your Myeloma Therapy: BLENREP image

More from HealthTree